Summary

  • At 30 June 2026, Stantec reported CA$9.2363 billion of contract backlog, up 17.5% year on year; it attributes the change to 7.8 percentage points from acquisitions, 2.7 from foreign exchange and 7.0 from organic growth.
  • Management describes that aggregate backlog as approximately 13 months of work. The filing does not turn it into a project-by-project schedule, future revenue forecast, margin forecast or collection timetable.
  • First-half operating cash flow was CA$116.3 million, CA$118.4 million below the comparable period, while DSO was 75 days. Those observations belong to a separate cash and working-capital clock.

A stock, with a stated composition

The 17.5% number needs its labels attached. Stantec’s Q2 2026 MD&A says its backlog rose from CA$7.8563 billion a year earlier to CA$9.2363 billion at 30 June. It then divides the reported year-on-year increase into 7.8 percentage points from acquisitions, 2.7 points from foreign exchange and 7.0 points from organic growth.

That is more informative than a bare total because the components are not interchangeable. An acquired practice enters the corporate perimeter through a transaction. Foreign exchange changes the Canadian-dollar presentation of work already held in another currency. Organic growth is the company’s stated residual for expansion within its continuing business. Each can enlarge a reported backlog stock. None answers the separate question of which named project will be performed, accepted, invoiced or paid in a particular month.

Stantec adds that the CA$9.2363 billion represents approximately 13 months of work. The qualifier matters. It is an aggregate management description of a pipeline of remaining awarded work, not a delivery diary. The filing does not allocate the 13 months by client, geography, contract type, acquisition, margin or payment term. It does not say how much of the acquisition component sits in any period, nor does it put a date beside the cash that work may eventually produce.

Treating a stock as if it were a calendar creates an apparently precise conclusion from a disclosure that deliberately remains aggregate. The more disciplined reading is narrower: there is a large reported work base, and Stantec tells readers which broad sources account for its year-on-year change.

Revenue is another observation

The quarter’s net revenue was CA$1.7806 billion, 11.5% above the prior-year quarter. Here too the MD&A distinguishes its components: 3.7 percentage points of organic growth, 7.1 points from acquisitions and 0.7 points from foreign exchange. Revenue records work recognized in the reported period. Backlog describes remaining awarded work at a date. Their percentage splits are related disclosures, but they do not form a conversion equation.

The difference is practical for public and institutional infrastructure buyers as well as investors. An award can support capacity planning; performance still depends on project execution, client decisions and the terms that govern acceptance. Revenue recognition then follows the applicable performance and accounting conditions. The June filing supplies aggregate numbers, not the individual contract bridge that would turn a work stock into a date-specific revenue path.

This is not a reason to dismiss the backlog figure. It is a reason not to lend it an authority that belongs to a different receipt. A growth contribution is not automatically a delivery contribution; an aggregate work horizon is not automatically a quarterly revenue schedule.

Cash keeps its own clock

The MD&A gives a useful counterweight to that category error. Stantec reported CA$118.6 million of operating cash flow in the second quarter, CA$15.4 million lower than in the comparable 2025 quarter. For the first half, operating cash flow was CA$116.3 million, CA$118.4 million lower year on year. Management attributes the first-half difference to net working-capital effects related to revenue growth, 2025 acquisitions and Page integration. It does not assign a dollar amount to each factor.

DSO was 75 days at 30 June, two days above the prior year and at the company’s stated internal target. The financial statements separately show CA$1.4401 billion of trade receivables, CA$831.3 million of unbilled receivables and CA$133.8 million of contract assets. Those balances document positions at a reporting date. They do not disclose a collection date, a client-by-client outcome or a causal link to a particular backlog component.

The sequence matters: awarded remaining work, performance, recognized revenue, invoicing or an unconditional payment right, and cash collection are different operational and evidentiary stages. The documents do not provide the bridge across every stage. They do provide enough to keep the stages separate.

What later evidence can settle

The next useful disclosure would not be a louder backlog headline. It would clarify the things this filing does not allocate: whether the mix of acquisition, exchange and organic contributions changes; whether the approximate work horizon shifts; how revenue, receivables, unbilled balances and operating cash move together; and whether management offers a more specific working-capital bridge.

Until then, the supported conclusion is modest. Stantec reported a growing backlog with three named sources of change. It also reported revenue and cash measures that run on different clocks. The filing supports monitoring their future reconciliation, not writing a calendar or cash forecast that is absent from the record.

Sources

  1. Stantec Q2 2026 MD&A
  2. Stantec Form 6-K, filed 12 August 2026
  3. Stantec Q2 2026 financial statements
  4. SEC filing index for Stantec’s Q2 2026 Form 6-K